Home > Medical Reference > Patient Education

Services at the UM Medical Center

See a complete list of Specialty Services and Departments at UMMC.

Hepatitis

Description

An in-depth report on the causes, diagnosis, treatment, and prevention of hepatitis.


Highlights

Drug Approval

Peginterferon alfa-2a (Pegasys) was approved in 2005 for treatment of chronic hepatitis B. The injectable drug was previously approved for chronic hepatitis C.

Drug Warning

Patients with hepatitis A or B should not take acetaminophen (Tylenol), according to research presented at the 2006 Digestive Disease Week conference. The nonprescription pain reliever may increase the risk of liver failure.

Herbal Remedies

Milk thistle does not reduce deaths from hepatitis B or C liver diseases, according to a Cochrane Database review.

Hepatitis A

Hepatitis B

Hepatitis C


A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial process . A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997-2007 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.
adam.com